Medicare’s approach to Alzheimer’s is not just outdated—it is discriminatory. This report lays out how federal policy has systematically blocked access to modern diagnostics and treatments, delaying care for millions and denying patients the chance to act early, plan ahead, and access innovation. Read the full analysis to understand what’s at stake—and what must change.